156 related articles for article (PubMed ID: 31569763)
1. Calcium Phosphate Nanoparticle-Based Vaccines as a Platform for Improvement of HIV-1 Env Antibody Responses by Intrastructural Help.
Damm D; Rojas-Sánchez L; Theobald H; Sokolova V; Wyatt RT; Überla K; Epple M; Temchura V
Nanomaterials (Basel); 2019 Sep; 9(10):. PubMed ID: 31569763
[TBL] [Abstract][Full Text] [Related]
2. Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines.
Elsayed H; Nabi G; McKinstry WJ; Khoo KK; Mak J; Salazar AM; Tenbusch M; Temchura V; Überla K
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743369
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune responses to liposomal vaccines by intrastructural help.
Damm D; Suleiman E; Wagner JT; Klessing S; Pfister F; Elsayed H; Walkenfort B; Stobrawe J; Mayer J; Lehner E; Müller-Schmucker SM; Hasenberg M; Wyatt RT; Vorauer-Uhl K; Temchura V; Überla K
Eur J Pharm Biopharm; 2023 Nov; 192():112-125. PubMed ID: 37797679
[TBL] [Abstract][Full Text] [Related]
4. Design and Functional Characterization of HIV-1 Envelope Protein-Coupled T Helper Liposomes.
Damm D; Suleiman E; Theobald H; Wagner JT; Batzoni M; Ahlfeld Née Kohlhauser B; Walkenfort B; Albrecht JC; Ingale J; Yang L; Hasenberg M; Wyatt RT; Vorauer-Uhl K; Überla K; Temchura V
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890282
[TBL] [Abstract][Full Text] [Related]
5. CD4
Klessing S; Temchura V; Tannig P; Peter AS; Christensen D; Lang R; Überla K
Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33066267
[TBL] [Abstract][Full Text] [Related]
6. GagPol-specific CD4⁺ T-cells increase the antibody response to Env by intrastructural help.
Nabi G; Genannt Bonsmann MS; Tenbusch M; Gardt O; Barouch DH; Temchura V; Uberla K
Retrovirology; 2013 Oct; 10():117. PubMed ID: 24156704
[TBL] [Abstract][Full Text] [Related]
7. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
[TBL] [Abstract][Full Text] [Related]
8. Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines.
Temchura V; Überla K
Curr Opin HIV AIDS; 2017 May; 12(3):272-277. PubMed ID: 28422791
[TBL] [Abstract][Full Text] [Related]
9. Covalent coupling of HIV-1 glycoprotein trimers to biodegradable calcium phosphate nanoparticles via genetically encoded aldehyde-tags.
Damm D; Kostka K; Weingärtner C; Wagner JT; Rojas-Sánchez L; Gensberger-Reigl S; Sokolova V; Überla K; Epple M; Temchura V
Acta Biomater; 2022 Mar; 140():586-600. PubMed ID: 34968725
[TBL] [Abstract][Full Text] [Related]
10. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
11. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
12. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
[TBL] [Abstract][Full Text] [Related]
13. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
[TBL] [Abstract][Full Text] [Related]
14. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
J Virol; 2017 May; 91(9):. PubMed ID: 28202751
[TBL] [Abstract][Full Text] [Related]
15. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.
Crooks ET; Moore PL; Franti M; Cayanan CS; Zhu P; Jiang P; de Vries RP; Wiley C; Zharkikh I; Schülke N; Roux KH; Montefiori DC; Burton DR; Binley JM
Virology; 2007 Sep; 366(2):245-62. PubMed ID: 17580087
[TBL] [Abstract][Full Text] [Related]
16. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
[TBL] [Abstract][Full Text] [Related]
17. A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.
Perdiguero B; Sánchez-Corzo C; Sorzano COS; Saiz L; Mediavilla P; Esteban M; Gómez CE
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781504
[TBL] [Abstract][Full Text] [Related]
18. Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine.
Schwerdtfeger M; Andersson AC; Neukirch L; Holst PJ
J Transl Med; 2019 May; 17(1):175. PubMed ID: 31126293
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination.
Torrents de la Peña A; de Taeye SW; Sliepen K; LaBranche CC; Burger JA; Schermer EE; Montefiori DC; Moore JP; Klasse PJ; Sanders RW
J Virol; 2018 Apr; 92(8):. PubMed ID: 29367243
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.
Gonelli CA; King HAD; Mackenzie C; Sonza S; Center RJ; Purcell DFJ
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33801906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
